Delivery Order SPE2DB22D2009-SPE2DB25FL9LV
Award Date
5/29/25
Potential Completion Date
6/20/25
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for PROQUAD VIALS, a medical supply, with a firm fixed price ceiling value of $1,601.99. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This is a $2,740.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a completion date of June 12, 2025. The contract is not set aside and was awarded on May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a $4,711.62 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4,564,483,817 PROQUAD VIALS, with a completion date of May 23, 2024. The awarding agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
This is a $5,015.10 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a period of performance through September 11, 2024. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,432.20 fixed-price contract is for the delivery of PROQUAD VIALS medical supplies, with a performance period ending on May 27, 2025. The order is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,910,641 PROQUAD VIALS. The delivery order has a completion date of March 27, 2024 and a potential value of $2,557.96. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 from DLA, which serves as the primary vehicle for the company to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,617.32 firm fixed-price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a period of performance through April 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has a ceiling value of $5,479.52 and a period of performance ending on April 29, 2025. The award is not set aside and was made on April 8, 2025. AmerisourceBergen Drug Corp is a for-profit organization that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has a total ceiling value of $1,687.48 and is a firm fixed-price, non-set-aside contract with a performance period through May 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...